Cardiovascular Sciences, a corporation under the laws of Nevada and a client company of the High Technology Incubator at the University of Central Florida, has reached a partnership agreement with Medical Technologies Enterprises of Palm Harbor, Florida.
Subscribe to our email newsletter
The agreement allows for an equity-sparing, stepping up the pace of development of Cardiovascular Sciences’s anti-adhesion technology and allows Medical Technologies Enterprises’s access to and early entry into markets with needs addressed by this technology and other related technologies.
Larry Hooper, CEO of Cardiovascular Sciences, said: “Initially, there will be an economy resulting from sharing many of the administrative operations of the two companies. Second, it gives us a retail presence in the marketplace and on the web. It is seldom that a company, at this stage in the development of its primary medical technology, has revenue generating retail market presence.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.